In a harsh warning letter, the FDA has reprimanded Sanofi-Aventis for failing to meet regulatory deadlines for reporting serious side effects with many of its drugs, including the Lovenox blood thinner, the Multaq heart drug and the Allegra D allergy pill, and also did not report post-marketing studies or completed, unpublished clinical trials in NDA annual reports.
Read article at pharmalot.com
Showing posts with label Multaq. Show all posts
Showing posts with label Multaq. Show all posts
Friday, 25 February 2011
Sanofi Failed To Report Side Effects
Subscribe to:
Posts (Atom)